Northern Trust’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23M Buy
976,512
+21,277
+2% +$543K ﹤0.01% 1587
2025
Q4
$27.7M Buy
955,235
+15,033
+2% +$385K ﹤0.01% 1459
2025
Q3
$17.7M Buy
940,202
+11,514
+1% +$182K ﹤0.01% 1769
2025
Q2
$13M Sell
928,688
-47,382
-5% -$664K ﹤0.01% 1914
2025
Q1
$15.3M Sell
976,070
-14,986
-2% -$211K ﹤0.01% 1792
2024
Q4
$13.8M Buy
991,056
+54,541
+6% +$598K ﹤0.01% 1938
2024
Q3
$8.71M Buy
936,515
+184,665
+25% +$1.82M ﹤0.01% 2148
2024
Q2
$6.99M Buy
751,850
+2,905
+0.4% +$26.3K ﹤0.01% 2206
2024
Q1
$7.42M Buy
748,945
+18,201
+2% +$136K ﹤0.01% 2235
2023
Q4
$2.36M Buy
730,744
+247,245
+51% +$672K ﹤0.01% 2902
2023
Q3
$2.57M Buy
483,499
+17,846
+4% +$152K ﹤0.01% 2802
2023
Q2
$4.44M Buy
465,653
+78,792
+20% +$875K ﹤0.01% 2570
2023
Q1
$4.26M Buy
386,861
+2,009
+0.5% +$29.1K ﹤0.01% 2562
2022
Q4
$5.7M Buy
384,852
+11,151
+3% +$195K ﹤0.01% 2404
2022
Q3
$7.14M Buy
373,701
+58,643
+19% +$1.33M ﹤0.01% 2228
2022
Q2
$6.71M Buy
315,058
+56,121
+22% +$1.15M ﹤0.01% 2312
2022
Q1
$4.99M Sell
258,937
-11,016
-4% -$186K ﹤0.01% 2589
2021
Q4
$5.6M Sell
269,953
-566
-0.2% -$11.3K ﹤0.01% 2619
2021
Q3
$6.46M Sell
270,519
-19,584
-7% -$447K ﹤0.01% 2576
2021
Q2
$7.92M Buy
290,103
+23,285
+9% +$656K ﹤0.01% 2532
2021
Q1
$7.72M Buy
266,818
+26,563
+11% +$829K ﹤0.01% 2468
2020
Q4
$6.76M Buy
240,255
+29,987
+14% +$734K ﹤0.01% 2495
2020
Q3
$6.16M Buy
210,268
+81,938
+64% +$2.19M ﹤0.01% 2404
2020
Q2
$3.88M Buy
128,330
+19,871
+18% +$574K ﹤0.01% 2667
2020
Q1
$3.23M Buy
+108,459
New +$2.91M ﹤0.01% 2566

Other funds holding ARQT